Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology

Edinburgh-based biotech company Ingenza Ltd. has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Ingenza has been working closely with researchers at Oxford University and the UK CPI, Wilton, since the start of the outbreak, and the collaboration is continuing to make excellent progress.

The team’s latest milestone success is the efficient production, using engineered yeast, of the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. When displayed on a novel virus-like particle (VLP) – developed and produced by the Oxford team also using a recombinant microbe – the resulting prototype vaccine elicits a powerful immunogenic response in mouse studies.

The results stem from the Scottish company’s unique combination of bioprocessing skills, including decades of experience and expertise in molecular biology. Downstream assays are now underway to validate and optimise the production technology for pre-clinical testing and, if successful, this will lead to a novel and cost-effective fully-microbial biomanufacturing platform to support rapid scale-up and high adaptability for future vaccine needs.

Ian Fotheringham, Managing Director of Ingenza, commented: “It is a huge privilege to be involved with our collaborators on this project and the progress we are making is extremely positive and exciting. We are proud to be applying our expertise in sustainable and cost-effective biomanufacturing to this global crisis and look forward to helping the world’s scientists develop a novel COVID-19 vaccine.”

For more information, visit www.ingenza.com or email sarah.scott@ingenza.com



Latest


28 Sep 2020
Analysing Mercury and other hydride forming Metalloids with PS Analytica

P S Analytical is a leading company in the manufacture and supply of instrumentation for the analysis of Mercury (Hg),…

Analysing Mercury and other hydride forming Metalloids with PS Analytica

P S Analytical is a leading company in the manufacture and supply of instrumentation for the analysis of Mercury (Hg), Arsenic (As), Selenium (Se), Antimony (Sb), Bismuth (Bi) and Tellurium (Te) in all matrices. Systems generally utilise Atomic Fluorescence Spectroscopy which offers many advantages over other techniques (such as Atomic…

27 Aug 2020
Electromagnetic flowmeters upgrade

Instrotech has announced that the Kobold magnetic inductive flowmeters MIM and MIS have been upgraded and further developed. Kobold MIM,…

Electromagnetic flowmeters upgrade

Instrotech has announced that the Kobold magnetic inductive flowmeters MIM and MIS have been upgraded and further developed. Kobold MIM, for measuring and monitoring of conductive liquids, is available for nominal sizes, ½” to 2”, and measuring ranges from 15ml/min to 350l/min. The new remote version, still manufactured in stainless…

26 Aug 2020
Labotec’s Precision Furnace Series

The Labotec Precision Furnace Series consists of ashing, muffle, fibre and ceramic chamber furnaces. They provide an excellent fit for…

Labotec’s Precision Furnace Series

The Labotec Precision Furnace Series consists of ashing, muffle, fibre and ceramic chamber furnaces. They provide an excellent fit for scientific laboratories, educational institutions, ceramic studios, medicine and industry as they are designed for material testing and heat treatments firing up to 1 300°C. Fibre chamber furnaces The high accuracy…

26 Aug 2020
Calibration bath or dry-well calibrator – which is the right choice?

Temperature sensors – like all other sensors – must be calibrated at regular intervals. This ensures they deliver accurate and…

Calibration bath or dry-well calibrator – which is the right choice?

Temperature sensors – like all other sensors – must be calibrated at regular intervals. This ensures they deliver accurate and consistent measured values. Temperature calibration (e.g. using a calibration bath or dry-well calibrator) is generally carried out by measuring temperature points within the temperature range of the probe. The results…


Top stories


04 Aug 2020
Pandemic fast-tracks progress in air freight supply chain

No going back to the old normal for the pharma air freight supply chain Few – if any – air…

Pandemic fast-tracks progress in air freight supply chain

No going back to the old normal for the pharma air freight supply chain Few – if any – air freight supply chain stakeholders envisaged a global pandemic and air traffic shutdown in their business continuity plans, and all had to react quickly, collaboratively and innovatively to cope with the…

04 May 2020
Pfeiffer Vacuum showcases Hena 50 and Hena 70 powerful vacuum pumps for mass spectrometer systems

Air and Vacuum Technologies represent Pfeiffer Vacuum in South Africa and supply Hena 50 and 70 vacuum pumps.

Pfeiffer Vacuum showcases Hena 50 and Hena 70 powerful vacuum pumps for mass spectrometer systems

Air and Vacuum Technologies represent Pfeiffer Vacuum in South Africa and supply Hena 50 and 70 vacuum pumps.

10 Mar 2020
Treating wastewater with ozone could convert pharmaceuticals into toxic compounds

With water scarcity intensifying, wastewater treatment and reuse are gaining popularity. But some methods for killing microbes in wastewater create…

Treating wastewater with ozone could convert pharmaceuticals into toxic compounds

With water scarcity intensifying, wastewater treatment and reuse are gaining popularity. But some methods for killing microbes in wastewater create disinfection byproducts (DBPs) that could be harmful to human health. Now researchers have found that ozone treatment and subsequent chlorination can convert trace amounts of some pharmaceuticals in wastewater into…

02 Mar 2020
Cannabis compound acts as an antibiotic

Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity’s most critical challenges. However, scientists…

Cannabis compound acts as an antibiotic

Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity’s most critical challenges. However, scientists haven’t discovered a new class of antibiotics in more than 30 years. Now, researchers reporting in ACS Infectious Diseases have uncovered the hidden antibiotic potential of a non-psychoactive cannabis compound called cannabigerol…


Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za